Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Marini

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 28, 2016
An open-label, single-dose, phase 1 study of the absorption, metabolism and excretion of quizartinib, a highly selective and potent FLT3 tyrosine kinase inhibitor, in healthy male subjects, for the treatment of acute myeloid leukemiaMadhu Sanga, Joyce James, Joseph Marini, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 16, 2012
Preclinical evaluation of the metabolism and disposition of RRx-001, a novel investigative anticancer agentJan Scicinski, Bryan Oronsky, Michael Taylor, et al.
International Journal of Toxicology|September 30, 2008
Effects of administration of a monoclonal antibody against mouse tumor necrosis factor alpha during pregnancy and lactation on the pre- and postnatal development of the mouse immune systemPauline L Martin, Joel B Cornacoff, George Treacy, et al.
Environmental Toxicology and Chemistry|August 23, 2025
Control Performance of the Extended Amphibian Metamorphosis Assay with the African clawed frog Xenopus laevisKatherine K Coady, Zhenglei Gao, Laurent Lagadic, et al.
Developmental Biology|May 29, 2017
The nuclear hormone receptor gene Nr2c1 (Tr2) is a critical regulator of early retina cell patterningAna Maria Olivares, Yinan Han, David Soto, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
A phase 1, randomized study to assess the pharmacokinetic comparability of siltuximab derived from two different cell lines in healthy subjectsChao Xu, Chao Han, Joseph Marini, et al.
The AAPS Journal|December 4, 2019
Recommendations for the Development and Validation of Immunogenicity Assays in Support of Biosimilar ProgramsFrancesca Civoli, Aparna Kasinath, Xiao-Yan Cai, et al.
Environmental Toxicology and Chemistry|March 10, 2025
Evaluation of in vivo fish and amphibian endocrine test guideline assays: current status and future needsNatalie Burden, Constance A Mitchell, Zhichao Dang, et al.
Journal of Medicinal Chemistry|November 24, 2005
2-(Quinazolin-4-ylamino)-[1,4]benzoquinones as covalent-binding, irreversible inhibitors of the kinase domain of vascular endothelial growth factor receptor-2Allan Wissner, M Brawner Floyd, Bernard D Johnson, et al.
Environmental Toxicology and Chemistry|February 4, 2025
Critical review of chronic toxicity testing approaches with the saltwater mysid (Americamysis bahia) used in pesticide registrationMargaret Fleming, Jane Staveley, Alan Samel, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 28, 2016
An open-label, single-dose, phase 1 study of the absorption, metabolism and excretion of quizartinib, a highly selective and potent FLT3 tyrosine kinase inhibitor, in healthy male subjects, for the treatment of acute myeloid leukemiaMadhu Sanga, Joyce James, Joseph Marini, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 16, 2012
Preclinical evaluation of the metabolism and disposition of RRx-001, a novel investigative anticancer agentJan Scicinski, Bryan Oronsky, Michael Taylor, et al.
International Journal of Toxicology|September 30, 2008
Effects of administration of a monoclonal antibody against mouse tumor necrosis factor alpha during pregnancy and lactation on the pre- and postnatal development of the mouse immune systemPauline L Martin, Joel B Cornacoff, George Treacy, et al.
Environmental Toxicology and Chemistry|August 23, 2025
Control Performance of the Extended Amphibian Metamorphosis Assay with the African clawed frog Xenopus laevisKatherine K Coady, Zhenglei Gao, Laurent Lagadic, et al.
Developmental Biology|May 29, 2017
The nuclear hormone receptor gene Nr2c1 (Tr2) is a critical regulator of early retina cell patterningAna Maria Olivares, Yinan Han, David Soto, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
A phase 1, randomized study to assess the pharmacokinetic comparability of siltuximab derived from two different cell lines in healthy subjectsChao Xu, Chao Han, Joseph Marini, et al.
The AAPS Journal|December 4, 2019
Recommendations for the Development and Validation of Immunogenicity Assays in Support of Biosimilar ProgramsFrancesca Civoli, Aparna Kasinath, Xiao-Yan Cai, et al.
Environmental Toxicology and Chemistry|March 10, 2025
Evaluation of in vivo fish and amphibian endocrine test guideline assays: current status and future needsNatalie Burden, Constance A Mitchell, Zhichao Dang, et al.
Journal of Medicinal Chemistry|November 24, 2005
2-(Quinazolin-4-ylamino)-[1,4]benzoquinones as covalent-binding, irreversible inhibitors of the kinase domain of vascular endothelial growth factor receptor-2Allan Wissner, M Brawner Floyd, Bernard D Johnson, et al.
Environmental Toxicology and Chemistry|February 4, 2025
Critical review of chronic toxicity testing approaches with the saltwater mysid (Americamysis bahia) used in pesticide registrationMargaret Fleming, Jane Staveley, Alan Samel, et al.
Pageof 2